AGIOS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Agios Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q3 2024.
  • Agios Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 57M shares, a 2.04% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 57M +1.14M +2.04% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 56.9M +1.14M +2.05% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 56.8M +1.21M +2.18% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 55.9M +905K +1.65% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 55.9M +990K +1.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 55.7M +919K +1.68% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 55.5M +765K +1.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 55M +705K +1.3% Dec 31, 2022 10-K 2024-02-15
Q3 2022 54.9M +179K +0.33% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 54.8M -5.1M -8.51% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 54.8M -15M -21.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 54.3M -15M -21.6% Dec 31, 2021 10-K 2023-02-23
Q3 2021 54.7M -14.5M -20.9% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 59.9M -9.15M -13.2% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 69.8M +1.02M +1.49% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 69.3M +893K +1.31% Dec 31, 2020 10-K 2022-02-24
Q3 2020 69.2M +10.3M +17.5% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 69.1M +10.3M +17.5% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 68.8M +10.1M +17.3% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 68.4M +10.2M +17.5% Dec 31, 2019 10-K 2021-02-25
Q3 2019 58.9M +710K +1.22% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 58.7M +817K +1.41% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 58.7M +1.12M +1.94% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 58.2M +9.39M +19.2% Dec 31, 2018 10-K 2020-02-19
Q3 2018 58.2M +9.55M +19.6% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 57.9M +9.59M +19.8% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 57.5M +15.2M +35.8% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 48.8M +6.61M +15.6% Dec 31, 2017 10-K 2019-02-14
Q3 2017 48.6M +6.6M +15.7% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 48.3M +10.3M +27.1% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 42.4M +4.48M +11.8% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 42.2M +4.52M +12% Dec 31, 2016 10-K 2018-02-14
Q3 2016 42M +4.41M +11.7% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 38M +628K +1.68% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 37.9M +610K +1.64% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 37.7M +596K +1.61% Dec 31, 2015 10-K 2017-02-16
Q3 2015 37.6M +2.96M +8.55% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 37.4M +2.98M +8.65% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 37.3M +5.46M +17.1% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 37.1M +5.9M +18.9% Dec 31, 2014 10-K 2016-02-26
Q3 2014 34.6M +3.57M +11.5% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 34.4M +30.7M +813% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 31.8M Mar 31, 2014 10-Q 2014-05-09
Q4 2013 31.2M +27.6M +763% Dec 31, 2013 10-K 2015-02-24
Q3 2013 31.1M Sep 30, 2013 10-Q 2013-11-07
Q2 2013 3.77M Jun 30, 2013 10-Q 2013-09-05
Q4 2012 3.62M Dec 31, 2012 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.